References

The role of incretins in glucose homeostasis and diabetes treatment

10.1124/pr.108.000604 · 2008 · External reference

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus

2010 · External reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

10.1056/nejm199309303291401 · 1993 · External reference

Hyperinsulinemia as an independent risk factor for ischemic heart disease

10.1056/nejm199604113341504 · 1996 · External reference

Chronic administration of voglibose, an α-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 active in ob/ob mice

10.1124/jpet.108.148056 · 2009 · External reference

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

10.1017/s0007114507691648 · 2007 · External reference

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

10.2337/db07-1124 · 2008 · External reference

Multicentre, double-blind, randomized study of mitiglinide compared with nateglinide in type 2 diabetes mellitus patients in China

10.1177/147323000903700324 · 2009 · External reference

Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes

10.2337/diab.26.10.944 · 1977 · External reference

Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men

10.1016/j.metabol.2005.07.006 · 2006 · External reference

Risk factors for worsening to diabetes in subjects with impaired glucose tolerance

10.1007/bf00252262 · 1984 · External reference